ConductScience.org, home

Paper42948616PubMed

Ductal Carcinoma In Situ With Microinvasion Arising in a Breast Hamartoma: A Case Report and Review of Guidelines of Hamartoma Management.

Ertansel B and 5 others. Case Rep Surg, 2026.

Cite this record

ConductScience Library. Ductal Carcinoma In Situ With Microinvasion Arising in a Breast Hamartoma: A Case Report and Review of Guidelines of Hamartoma Management. Papers, record 42948616. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42948616

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ductal Carcinoma In Situ With Microinvasion Arising in a Breast Hamartoma: A Case Report and Review of Guidelines of Hamartoma Management.
Journal
Case Rep Surg
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-29

Source PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121076596Invasive ductal carcinoma in a mammary hamartoma: case report and review of the literature.Korean J Radiol2010https://conductscience.org/library/papers/21076596PubMed
212565210Invasive ductal carcinoma arising in a breast hamartoma: two case reports and a review of the literature.Clin Radiol2003https://conductscience.org/library/papers/12565210PubMed
330800034Benign Breast Tumours - Diagnosis and Management.Breast Care (Basel)2018https://conductscience.org/library/papers/30800034PubMed
46300956Unusual lesions of the breast.Radiol Clin North Am1983https://conductscience.org/library/papers/6300956PubMed
516848850Infiltrating ductal carcinoma and ductal carcinoma in situ associated with mammary hamartoma.Breast J2006https://conductscience.org/library/papers/16848850PubMed
610882247In situ and infiltrating ductal carcinoma arising in a breast hamartoma.AJR Am J Roentgenol2000https://conductscience.org/library/papers/10882247PubMed
729554537Ductal Carcinoma in situ of the breast in sclerosing adenosis encapsulated by a hamartoma: A case report.Int J Surg Case Rep2018https://conductscience.org/library/papers/29554537PubMed
85096305The identification and treatment of mammary hamartoma.Surg Gynecol Obstet1971https://conductscience.org/library/papers/5096305PubMed
97785651Hamartoma of the breast, an underrecognized breast lesion. A clinicopathologic and radiographic study of 25 cases.Am J Clin Pathol1995https://conductscience.org/library/papers/7785651PubMed
1032101663Pembrolizumab for Early Triple-Negative Breast Cancer.N Engl J Med2020https://conductscience.org/library/papers/32101663PubMed
1112121234Breast hamartomas: clinicopathological and immunohistochemical studies of 24 cases.Histopathology2002https://conductscience.org/library/papers/12121234PubMed
1212101205Ductal carcinoma in situ arising in mammary hamartoma.J Clin Pathol2002https://conductscience.org/library/papers/12101205PubMed
1325141109Breast hamartoma: a clinicopathologic analysis of 27 cases and a literature review.Clinics (Sao Paulo)2014https://conductscience.org/library/papers/25141109PubMed
1411328316Hamartomas of the breast: clinical, radiologic, and pathologic manifestations.Breast J2001https://conductscience.org/library/papers/11328316PubMed
154128204Muscular hamartomas of the breast.J Pathol1973https://conductscience.org/library/papers/4128204PubMed
1638061151European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO.Eur J Surg Oncol2024https://conductscience.org/library/papers/38061151PubMed
1739471995Myoid Hamartoma of the Breast With HMGA2 Rearrangement and Associated In-Situ and Invasive Carcinoma: Case Report and Review of Literature.Int J Surg Pathol2025https://conductscience.org/library/papers/39471995PubMed
1831659109Genetic Characterization of Myoid Hamartoma of the Breast.Cancer Genomics Proteomics2019https://conductscience.org/library/papers/31659109PubMed
1934651111Breast Hamartoma: Clinical, Radiological, and Histopathological Evaluation.Eur J Breast Health2021https://conductscience.org/library/papers/34651111PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42948616

GET https://conductscience.org/api/papers/v1/42948616/authors